These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 24642104)

  • 21. Juvenile polyautoimmunity in a rheumatology setting.
    Malagón C; Gomez MDP; Mosquera C; Vargas C; Gonzalez T; Arango C; Martin L; Perez P; Amaya-Uribe L; Molano-Gonzalez N; Anaya JM
    Autoimmun Rev; 2019 Apr; 18(4):369-381. PubMed ID: 30772494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chikungunya virus and autoimmunity.
    Tanay A
    Curr Opin Rheumatol; 2017 Jul; 29(4):389-393. PubMed ID: 28376065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Biologics and mycobacterial diseases].
    Tsuyuguchi K; Matsumoto T
    Kekkaku; 2013 Mar; 88(3):337-53. PubMed ID: 23672175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring by rheumatologists for methotrexate-, etanercept-, infliximab-, and anakinra-associated adverse events.
    Yazici Y; Erkan D; Paget SA
    Arthritis Rheum; 2003 Oct; 48(10):2769-72. PubMed ID: 14558081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Emerging Epigenetic Role of CD8+T Cells in Autoimmune Diseases: A Systematic Review.
    Deng Q; Luo Y; Chang C; Wu H; Ding Y; Xiao R
    Front Immunol; 2019; 10():856. PubMed ID: 31057561
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of autoimmune rheumatic disease: state of the art and future perspectives.
    Klareskog L; Gregersen PK; Huizinga TW
    Ann Rheum Dis; 2010 Dec; 69(12):2062-6. PubMed ID: 21097657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term use of biologic agents does not increase the risk of serious infections in elderly patients with rheumatoid arthritis.
    Kawashima H; Kagami SI; Kashiwakuma D; Takahashi K; Yokota M; Furuta S; Iwamoto I
    Rheumatol Int; 2017 Mar; 37(3):369-376. PubMed ID: 27999943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Innate immunity, epigenetics and autoimmunity in rheumatoid arthritis.
    Maciejewska Rodrigues H; Jüngel A; Gay RE; Gay S
    Mol Immunol; 2009 Nov; 47(1):12-8. PubMed ID: 19232437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tapering biologics in rheumatoid arthritis: a pragmatic approach for clinical practice.
    Lenert A; Lenert P
    Clin Rheumatol; 2017 Jan; 36(1):1-8. PubMed ID: 27896522
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmunity in 2014.
    Selmi C
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):93-9. PubMed ID: 26335699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells: the driving force behind autoimmunity in rheumatoid arthritis?
    Pettit AR; Thomas R
    Immunol Cell Biol; 1999 Oct; 77(5):420-7. PubMed ID: 10540208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conference scene: shining lights on the future of autoimmunity in Asia.
    Perricone C; Perricone R
    Immunotherapy; 2012 Mar; 4(3):263-7. PubMed ID: 22401631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of three anti-TNFalpha biologics on existing and emergent autoimmunity in rheumatoid arthritis and spondylarthropathy patients.
    Bacquet-Deschryver H; Jouen F; Quillard M; Ménard JF; Goëb V; Lequerré T; Mejjad O; Daragon A; Tron F; Le Loët X; Vittecoq O
    J Clin Immunol; 2008 Sep; 28(5):445-55. PubMed ID: 18587633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of rheumatologists vis-à-vis assessment of traditional cardiovascular risk factors in rheumatoid arthritis.
    Luck Y; Baron M; Bardakjian S; Berkson L; Buchignani M; Fallavolita S; Giac F; Gyger G; Tatibouet S; Hudson M
    Clin Rheumatol; 2014 Jun; 33(6):769-74. PubMed ID: 24526251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoimmunity in 2009.
    Selmi C
    Autoimmun Rev; 2010 Oct; 9(12):795-800. PubMed ID: 20716447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunotherapeutic Biologic Agents in Autoimmune and Autoinflammatory Diseases.
    Ostrov BE
    Immunol Invest; 2015; 44(8):777-802. PubMed ID: 26575464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should the clinician have interest in the deregulation of apoptosis in autoimmunity?
    Graninger WB; Smolen JS
    Br J Rheumatol; 1997 Dec; 36(12):1244-6. PubMed ID: 9448583
    [No Abstract]   [Full Text] [Related]  

  • 38. Epigenetic control of autoimmune diseases: from bench to bedside.
    Picascia A; Grimaldi V; Pignalosa O; De Pascale MR; Schiano C; Napoli C
    Clin Immunol; 2015 Mar; 157(1):1-15. PubMed ID: 25576661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coffee and autoimmunity: More than a mere hot beverage!
    Sharif K; Watad A; Bragazzi NL; Adawi M; Amital H; Shoenfeld Y
    Autoimmun Rev; 2017 Jul; 16(7):712-721. PubMed ID: 28479483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Natural products action on pathogenic cues in autoimmunity: Efficacy in systemic lupus erythematosus and rheumatoid arthritis as compared to classical treatments.
    Cao F; Cheng MH; Hu LQ; Shen HH; Tao JH; Li XM; Pan HF; Gao J
    Pharmacol Res; 2020 Oct; 160():105054. PubMed ID: 32645358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.